MIRA INFORM REPORT

 

 

Report No. :

348361

Report Date :

07.11.2015

 

IDENTIFICATION DETAILS

 

Name :

N.K.P. PHARMA PRIVATE LIMITED

 

 

Registered Office :

Plot No.1814-B, Phase-III, GIDC Vatva, Ahmedabad – 382445, Gujarat

Tel. No.:

91-79-25890834/ 25891746

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

08.10.2008

 

 

Com. Reg. No.:

04-055212

 

 

Capital Investment / Paid-up Capital :

Rs. 3.000 Million

 

 

CIN No.:

[Company Identification No.]

U01403GJ2008PTC055212

 

 

IEC No.:

0800004833

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMN03820F

 

 

PAN No.:

[Permanent Account No.]

AACCN8804E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Machineries.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (42)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 129000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2008, having satisfactory track record.

 

For the year 2014, the company has recorded decline in its revenue and profit margin as compared to previous year, however it has achieved decent revenue marked by satisfactory profitability margin.

 

The company possesses decent networth base but there is unfavorable gap between trade payables and receivables.

 

Trade relations are fair. Business is active. Payments are slow but correct.

 

The company can be considered for business dealings at usual trade terms and conditions.   

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 


 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Nilesh Bhatt

Designation :

Accounts Manager

Contact No.:

91-79-25890834

Date :

07.11.2015

 

 

LOCATIONS

 

Registered Office :

Plot No.1814-B, Phase-III, GIDC Vatva, Ahmedabad – 382445, Gujarat, India

Tel. No.:

91-79-25890834/ 25891746

Fax No.:

91-79-25894282

E-Mail :

mnshahco@gmail.com

sales@pharmamachineriesindia.com

info@nkppharma.com

accounts1@nkppharma.com

Website :

http://www.nkppharma.com

http://www.pharmamachineriesindia.com

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Mr. Darshan Natvarlal Mevada

Designation :

Director

Address :

S/O, Natwarlal Mevada, 40/B Uganda Park Society, Bahiravnath Road, Maninagar, Ahmedabad – 380008, Gujarat, India

Date of Appointment :

08.10.2008

DIN No.:

01818221

 

 

Name :

Mr. Hitesh Natvarlal Mevada

Designation :

Director

Address :

S/O, Natwarlal Mevada, 40/B Uganda Park Society, Bahiravnath Road, Maninagar, Ahmedabad – 380008, Gujarat, India

Date of Birth/Age :

04.08.1975

Date of Appointment :

08.10.2008

DIN No.:

01820149

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Equity Shareholders

 

No. of Shares

 

Hitesh N Mevada

 

4500

Darshan N Mevada

 

4500

Mittal H Mevada

 

20000

Payal D Mevada

 

20000

Natverlal R Mevada (HUF)

 

500

Rukhiben N. Mevada

 

9500

Darshan H Mevada (HUF)

 

8000

Hitesh N Mevada (HUF)

 

8000

Teeshan D Mevada

 

6250

Prem D Mevada

 

6250

Maan H Mevada

 

12500

 

 

 

Total

 

 

100000

 

 

Names of Preference Shareholders

 

No. of Shares

 

Darshan H Mevada (HUF)

 

1500

Hitesh N Mevada (HUF)

 

1500

Payal H Mevada

 

1000

Mittal H Mevada

 

1000

Natverlal R Mevada (HUF)

 

7500

Rukhiben N Mevada

 

7500

 

 

 

Total

 

 

20000

 

 

AS ON 30.09.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

83.50

Other top fifty shareholders

16.50

 

 

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Machineries.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         Bangladesh

·         South Africa

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

GT Metal and Tubes

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

 

Reference:

Sun Pharma Limited

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

·         The Kukarwada Nagrik Sahakari Bank Limited

Krishna Complex, Hathipura, Madhupura, Ahmedabad - 380004, Gujarat, India

 

·         HDFC Bank Limited

·         Axis Bank Limited

·         ICICI Bank Limited

 

Bank Name:

--

Branch:

--

Person Name (with Designation):

--

Contact Number:

--

Name of Account Holder:

--

Account Number:

--

Account Since (Date/ Year of A/c Opening):

--

Average Balance Maintained (Optional):

--

Credit Facilities Enjoyed (CC/OD/Term Loan):

--

Account Operation:

--

Remarks:

--

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term loan

Volkswagen Finance Private Limited

2.202

2.914

Axis Bank Limited

8.268

10.768

HDFC Bank Limited

(Secured By Hypothecation of Vehicle)

0.000

0.078

SHORT TERM BORROWINGS

 

 

Loan Repayable on Demand

From Banks

Cash Credit A\c

(secured by way of Hypothecation of inventories)

19.492

21.934

F.D. O.D. with Bank of Baroda

(Secured by way of FDR)

0.004

0.003

Current maturities of Long term borrowings

(Secured By Hypothecation of Vehicle)

2.127

2.914

 

 

 

Total

 

32.093

38.611

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Mahendra N. Shah and Company

Chartered Accountants

Address :

E/3 Capital Commercial Centre, Near Sanyas Ashram, Ashram Road, Ahmedabad – 380009, Gujarat, India

Income-tax PAN of auditor or auditor's firm :

AADFM4086H

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates/Subsidiaries :

Not Available

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100,000

Equity Shares

Rs. 10/- each

Rs. 1.000 Million

20,000

Preference Shares

Rs. 100/- each

Rs. 2.000 Million 

 

 

 

 

 

Total

 

Rs. 3.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100,000

Equity Shares

Rs. 10/- each

Rs. 1.000 Million

20,000

Preference Shares

Rs. 100/- each

Rs. 2.000 Million 

 

 

 

 

 

Total

 

Rs. 3.000 Million

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

3.000

3.000

3.000

(b) Reserves & Surplus

42.293

39.622

31.628

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

45.293

42.622

34.628

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

10.470

13.760

1.018

(b) Deferred tax liabilities (Net)

3.340

3.148

2.697

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

13.810

16.908

3.715

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

24.418

27.536

23.354

(b) Trade payables

79.377

60.807

71.715

(c) Other current liabilities

25.605

24.333

22.954

(d) Short-term provisions

8.530

9.872

19.202

Total Current Liabilities (4)

137.930

122.548

137.225

 

 

 

 

TOTAL

197.033

182.078

175.568

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

54.551

56.135

50.601

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

6.632

4.823

0.405

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

21.197

15.677

14.583

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.545

2.548

2.516

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

82.925

79.183

68.105

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

48.550

34.557

35.147

(c) Trade receivables

39.702

44.448

37.102

(d) Cash and cash equivalents

7.819

8.310

7.478

(e) Short-term loans and advances

18.037

15.580

27.736

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

114.108

102.895

107.463

 

 

 

 

TOTAL

197.033

182.078

175.568

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from Operations

153.353

181.100

172.158

 

 

Other Income

0.868

2.021

1.548

 

 

TOTAL                                     (A)

154.221

183.121

173.706

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

96.688

116.053

98.817

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(12.306)

(11.229)

4.930

 

 

Employees benefits expense

32.727

30.258

26.639

 

 

Other expenses

24.679

27.587

23.291

 

 

TOTAL                                     (B)

141.788

162.669

153.677

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

12.433

20.452

20.029

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

3.549

4.020

3.560

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

8.884

16.432

16.469

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

2.936

2.661

2.162

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

5.948

13.771

14.307

 

 

 

 

 

Less

TAX                                                                  (H)

1.967

4.466

4.904

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

3.981

9.305

9.403

 

 

 

 

 

 

Earnings Per Share (Rs.)

39.81

93.05

94.03

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

NA

NA

NA

 

 

 

 

Net Cash flow from (used in) Operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

2.60

5.14

5.46

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

8.11

11.29

11.63

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.52

8.52

8.91

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.13

0.32

0.41

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.77

0.97

0.70

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.83

0.84

0.78

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

3.000

3.000

3.000

Reserves & Surplus

31.628

39.622

42.293

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

34.628

42.622

45.293

 

 

 

 

Long-term borrowings

1.018

13.760

10.470

Short term borrowings

23.354

27.536

24.418

Total borrowings

24.372

41.296

34.888

Debt/Equity ratio

0.704

0.969

0.770

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

172.158

181.100

153.353

 

 

5.194

-15.321

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

172.158

181.100

153.353

Profit

9.403

9.305

3.981

 

5.46%

5.14%

2.60%

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

No

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 


 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10575331

06/06/2015

6,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

C56657430

2

10216797

16/01/2013 *

37,500,000.00

AXIS BANK LIMITED

GROUND FLOOR, BUSINESS SQUARE BUILDING,, NEAR KRI 
SHNA BAUG CHAR RASTA, MANINAGAR,, AHMEDABAD, GUJARAT - 380001, INDIA

B66897133

3

10211679

05/01/2013 *

37,500,000.00

AXIS BANK LIMITED

GROUND FLOOR, BUSINESS SQUARE BUILDING,, NEAR KRI 
SHNA BAUG CHAR RASTA, MANINAGAR,, AHMEDABAD, GUJARAT - 380008, INDIA

B66924994

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

SHORT TERM BORROWINGS

 

 

From Other Parties

Directors

0.061

0.857

Share Holders

2.734

1.828

 

 

 

Total

 

2.795

2.685

 

 

PERFORMANCE:

 

The Company has earned revenue from operations of Rs.153.353 Million as against Rs.181.100 Million in the previous year resulting a heavy reduction by 15.32 %. The Company is engaged in the business of manufacturing of Pharmaceutical machineries.

 

2013 – 14 started on a high with strong demand pull from the FMCG, Pharma, Industries, both in and outside of India. However, as the year progressed, the financial crisis deepened in Europe, the US industry indicators continued to remain weak resulting in an overall slowdown in demand in those economies which finally impacted the finished product price adversely, creating a price cost imbalance in strategic raw materials.

 

India, the weakening of the rupee put enormous inflationary pressures on the economy in the second half of the current year forcing the government to take fiscal measures which stagnated public spending, reduced capital outflow and consumer spending which eventually resulted into weakening of overall market demand for the final products of the Company’s customers. This in turn adversely impacted the Company’s volumes and prices in the second half of the year. As the Company is engaged in providing equipment and pharmaceutical machineries and almost all major pharmaceutical companies have put on hold their Capex Products or are delaying the same and waiting for the economy to turn-around. The forex fluctuations and strengthening of US $ against Indian Rupee has also adversely impacted the exports.

 

The profitability during the year is adversely impacted on account of factors as narrated above and also for the reasons that the Company has substantially invested in strengthening its labor force, skilled and unskilled man-power, which is a long term strategic measure to meet with the requirements and capture the opportunity whenever there is a positive improvement in the economic conditions.

 

The Company is rigorously pursuing various new markets and expanding its reach to new territories in the global market.

 

The Company has also upgraded its equipments to improve the quality of products to meet with the requirements of quality conscious export market.

 

The Directors are also hopeful of improved performance in the years to come.

 

 

FINANCE:

 

The Company is thankful to the bankers - Axis Bank Limited for lending valuable support of finance for the Working Operations of the Company. The Management acknowledges the timely Financial Assistance which has proved of immense use in developing and expanding the business operations of the Company.

 

 

FIXED ASSETS:

 

·         Land (Freehold)

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Other Equipment

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 65.79

UK Pound

1

Rs. 99.95

Euro

1

Rs. 71.55

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

AMR

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

42

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.